Pseudomonas aeruginosa JCM 14237 is a mesophilic prokaryote that was isolated from Feces.
mesophilic 16S sequence| @ref 20215 |
Last LPSN update
2025-12-16 10:08:45 |
| Domain Pseudomonadati |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Pseudomonadaceae |
| Genus Pseudomonas |
| Species Pseudomonas aeruginosa |
| Full scientific name Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Sample type | Geographic location | Country | Country ISO 3 Code | Continent | |
|---|---|---|---|---|---|---|
| 67770 | Feces | MT | USA | USA | North America |
Global distribution of 16S sequence LC508790 (>99% sequence identity) for Pseudomonas aeruginosa from Microbeatlas 
 Aquatic Samples |
5046 |
 Soil Samples |
1669 |
 Animal Samples |
14748 |
 Plant Samples |
1294 |
| Total Samples | 22757 |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 67770 | Pseudomonas aeruginosa JCM 14237 gene for 16S ribosomal RNA, partial sequence | LC508790 | 1458 |  | 287 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Antibiotic-Resistant Pseudomonas aeruginosa: Current Challenges and Emerging Alternative Therapies. | Hu M, Chua SL. | Microorganisms | 10.3390/microorganisms13040913 | 2025 |  | |
| Combatting Pseudomonas aeruginosa with beta-Lactam Antibiotics: A Revived Weapon? | Zhao DW, Lohans CT. | Antibiotics (Basel) | 10.3390/antibiotics14050526 | 2025 | | |
| Genomic analysis of vB_PaS-HSN4 bacteriophage and its antibacterial activity (in vivo and in vitro) against Pseudomonas aeruginosa isolated from burn. | Rafiei S, Bouzari M. | Sci Rep | 10.1038/s41598-023-50916-5 | 2024 | | |
| Pathogenicity | Bacteriophages, a New Therapeutic Solution for Inhibiting Multidrug-Resistant Bacteria Causing Wound Infection: Lesson from Animal Models and Clinical Trials. | Taati Moghadam M, Khoshbayan A, Chegini Z, Farahani I, Shariati A, Shariati A. | Drug Des Devel Ther | 10.2147/dddt.s251171 | 2020 | |
| Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections. | Pires DP, Vilas Boas D, Sillankorva S, Azeredo J. | J Virol | 10.1128/jvi.00385-15 | 2015 | | |
| Bacteriophage-Mediated Control of Biofilm: A Promising New Dawn for the Future. | Chang C, Yu X, Guo W, Guo C, Guo X, Li Q, Zhu Y. | Front Microbiol | 10.3389/fmicb.2022.825828 | 2022 | | |
| Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. | McVay CS, Velasquez M, Fralick JA. | Antimicrob Agents Chemother | 10.1128/aac.01028-06 | 2007 | | |
| Unexpected diversity and complexity of the Guerrero Negro hypersaline microbial mat. | Ley RE, Harris JK, Wilcox J, Spear JR, Miller SR, Bebout BM, Maresca JA, Bryant DA, Sogin ML, Pace NR. | Appl Environ Microbiol | 10.1128/aem.72.5.3685-3695.2006 | 2006 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive161468.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License